| Structure |
Chemical Name |
CAS |
MF |
 |
4-ヒドロキシ-2-オキソ-1-ピロリジン酢酸エチル |
62613-81-4 |
C8H13NO4 |
 |
Parecoxib Impurity 4 |
57736-10-4 |
C14H13NO |
![(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile](/CAS/20181212/GIF/1640971-60-3.gif) |
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile |
1640971-60-3 |
C14H20N6O |
 |
(1S,2R,3R)-Aprepitant |
1242175-34-3 |
C23H21F7N4O3 |
 |
Bortezomib Impurity Z |
|
|
 |
2-Chloro-4-nitrobenzaldehyde |
5568-33-2 |
C7H4ClNO3 |
 |
2-(3,7-ジメチル-2,6-オクタジエニル)-5-ペンチル-1,3-ベンゼンジオール |
2808-33-5 |
|
![6-アミノ-3-クロロイミダゾ[1,2-A]ピリジン](/CAS/GIF/1094463-26-9.gif) |
6-アミノ-3-クロロイミダゾ[1,2-A]ピリジン |
1094463-26-9 |
C7H6ClN3 |
 |
Olmesartan Medoxomil Impurity 4 |
95579-71-8 |
C5H5ClO3 |
 |
2-(tert-butylamino)-1-(4-ethoxy-3-(hydroxymethyl)phenyl)ethanol |
2387728-91-6 |
C15H25NO3 |
 |
Apixaban IMpurity 3 |
1801881-18-4 |
C25H25N5O4 |
 |
FaMotidine Acid IMpurity Methyl Ester |
76824-14-1 |
C9H14N4O2S2 |
 |
For the determination of
impurities in Propylene |
|
|
 |
OPIACE reference substance |
|
|
 |
Peramivir Impurity |
383910-24-5 |
C18H30N2O5 |
 |
2,5-ジヒドロキシ-3-メチル-6-(14-ノナデセニル)-2,5-シクロヘキサジエン-1,4-ジオン |
19833-20-6 |
C26H42O4 |
![Phenol, 4,4′-sulfonylbis-, Polymer mit 1,1′-Oxibis[2-chlorethan], EO 2-12 mol (75 % EO 2-6 mol)](/CAS/20240320/GIF/191680-83-8.gif) |
Phenol, 4,4′-sulfonylbis-, Polymer mit 1,1′-Oxibis[2-chlorethan], EO 2-12 mol (75 % EO 2-6 mol) |
191680-83-8 |
(C12H10O4S.C4H8Cl2O)x |
 |
5-(2-FLUOROPHENYL)-1-(PYRIDIN-2-YLSULFONYL)-1H-PYRROLE-3-CARBALDEHYDE |
928324-73-6 |
C16H11FN2O3S |
![4-Amino-6-ethoxy-5-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]azo]-α-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]hydrazono]-2-pyrimidineacetonitrile](/CAS/20210305/GIF/618458-79-0.gif) |
4-Amino-6-ethoxy-5-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]azo]-α-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]hydrazono]-2-pyrimidineacetonitrile |
618458-79-0 |
C30H30N12O3 |
 |
2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid |
407582-48-3 |
C12H8N2O3S |
 |
Ampicillin EP Impurity M |
62326-82-3 |
C32H38N6O8S2 |
 |
Clopidogrel EP Impurity B HCl |
1396607-35-4 |
C16H17Cl2NO2S |
 |
TaMsulosin EP IMpurity D |
1799280-05-9 |
C19H26N2O5S |
 |
For the determination of
impurities in lsobutylene |
|
|
 |
Metronidazole Impurity 10 |
56750-04-0 |
C7H11N3O3 |
 |
Iguratimod Impurity 10 |
149456-97-3 |
C18H20N2O6S |
 |
Pitavastatin Impurity 10 |
|
|
 |
(S)-1-(2-Chloroacetyl)pyrrolidine-2-carboxaMide |
214398-99-9 |
C7H11ClN2O2 |
 |
Parecoxib Sodium EJF |
2338845-31-9 |
C32H24N2O4S |
 |
Cilastatin Impurity C |
|
|
 |
Peramivir Impurity 31 |
2758048-80-3 |
C15H28N2O4 |
 |
Milrinone Impurity |
1443528-67-3 |
|
 |
Cefditoren Pivoxil Dimer |
|
|
 |
3-chloro-N,N-dimethyl-1-phenylpropan-1-amine hydrochloride |
81402-53-1 |
C11H17Cl2N |
 |
Ampicillin Glycolylurea Analogue |
|
|
 |
3-Isobutylglutarimid |
916982-10-0 |
C9H15NO2 |
 |
3-O-Methylcarbidopa |
85933-19-3 |
C11H16N2O4 |
 |
1,8,1',8'-tetrahydroxybisanthrone |
31991-54-5 |
C28H18O6 |
 |
α-メチル-4-(2-メチルプロピル)ベンゼンアセトアミド |
59512-17-3 |
C13H19NO |
 |
(6E)-9,10-セココレスタ-5(10),6,8-トリエン-3β-オール |
17592-07-3 |
C27H44O |
 |
Afatinib iMpurity |
1680184-59-1 |
C24H25ClFN5O3 |
 |
2-メチル-5-ニトロ-1H-イミダゾール-1-酢酸エチル |
1016-40-6 |
C8H11N3O4 |
 |
Fulvestrant Sterol DiMer |
|
|
 |
Cephalonium lactone |
10590-10-0 |
C14H12N2O4S2 |
![8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-6-vinylpyrido[2,3-d]pyrimidin-7(8H)-one](/CAS/20200331/GIF/2204863-06-7.gif) |
8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-6-vinylpyrido[2,3-d]pyrimidin-7(8H)-one |
2204863-06-7 |
C24H29N7O |
 |
cefotaxiMe IMpurity A |
|
|
 |
ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5- carboxylate |
2073891-59-3 |
C15H13NO5S |
 |
2-CHLORO-1-(4-ISOBUTYLPHENYL)PROPAN-1-ONE |
80336-66-9 |
C13H17ClO |
 |
3-オキソ-4-プレグネン-20β-アルデヒド |
3986-89-8 |
C22H32O2 |
 |
N-Desbutyl-N-propyl BuMetanide |
28395-28-0 |
C16H18N2O5S |
 |
2-(4-(sec-butoxy)-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid |
1335202-59-9 |
C16H16N2O3S |
 |
Macitentan Impurity 23 |
2365406-86-4 |
C12H11BrClN3O |
 |
Mizolastine Impurity 8 |
935860-12-1 |
C25H27FN6O |
 |
Trabectedin Intermediate A23 |
366020-68-0 |
C31H34N4O8S |
 |
Levocetirizine amide impurity HCl |
909779-33-5 |
C21H26ClN3O2 |
 |
1-(4-アミノフェニル)-3-モルホリノ-5,6-ジヒドロピリジン-2(1H)-オン |
1267610-26-3 |
C15H19N3O2 |
 |
(14S,16β,22R,25S)-5,6β:14,17:14,27-トリエポキシ-13,20,22-トリヒドロキシ-1,15-ジオキソ-16,24-シクロ-13,14-セコ-5β-エルゴスタ-2-エン-18,26-二酸18,20:26,22-ジラクトン |
57423-71-9 |
C28H30O10 |
 |
Dabigatran Impurity 8 |
1408238-40-3 |
C34H40N6O6 |
 |
H-DL-ALA-OET · HCL |
17344-99-9 |
C5H11NO2 |
![1-[1-(Bromomethyl)ethenyl]-2,4-difluoro-benzene](/CAS2/GIF/159276-58-1.gif) |
1-[1-(Bromomethyl)ethenyl]-2,4-difluoro-benzene |
159276-58-1 |
C9H7BrF2 |
 |
Amoxicillin EP Impurity L |
1789703-32-7 |
C24H29N5O7S2 |
 |
Parecoxib ImpurityO |
198470-91-6 |
C20H20N2O4S |
 |
(S)-3(2h)-Pyridazinone, 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl- |
101328-84-1 |
C11H13N3O |
 |
5-(4-フルオロフェニル)チオフェン-2-カルボン酸 |
115933-30-7 |
C11H7FO2S |
 |
サイコサポニンB3 |
58316-42-0 |
C43H72O14 |
![2-[4-(4-METHOXY-PHENOXY)-PHENYL]-MALONIC ACID MONO-(4-METHOXY-PHENYL) ESTER](/CAS/GIF/70175-90-5.gif) |
2-[4-(4-METHOXY-PHENOXY)-PHENYL]-MALONIC ACID MONO-(4-METHOXY-PHENYL) ESTER |
70175-90-5 |
C25H24O7 |
 |
Ascorbic acid EP Impurity G (L-threo-Hex-2-eneric acid, 1-4-lactone) |
66757-69-5 |
C6H6O7 |
 |
Brivaracetam Impurity 3 |
2432911-32-3 |
C15H27N3O3 |
 |
17-デスアセチルロクロニウム |
119302-86-2 |
C30H51BrN2O3 |
 |
Paliperidone Impurity 7 |
1415488-05-9 |
C27H45ClN2O3 |
 |
Ceftaroline Fosamil Impurity 8 |
1286218-63-0 |
C22H23N8O9PS4 |
 |
4-Methyl-N-(3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)phenyl)-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzaMide |
641571-15-5 |
C28H22F3N7O |
![(3R)-3β,4β-ジヒドロキシ-5α-[3-(3,4-ジヒドロキシフェニル)アクリロイルオキシ]-1-シクロヘキセン-1-カルボン酸](/CAS/GIF/73263-62-4.gif) |
(3R)-3β,4β-ジヒドロキシ-5α-[3-(3,4-ジヒドロキシフェニル)アクリロイルオキシ]-1-シクロヘキセン-1-カルボン酸 |
73263-62-4 |
C16H16O8 |
![[D-Pro2,D-Trp7,9]物質P](/CAS/GIF/80434-86-2.gif) |
[D-Pro2,D-Trp7,9]物質P |
80434-86-2 |
C74H106N20O13S |
 |
alpha-(3,4-dihydroxyphenyl)lactic acid |
22681-72-7 |
C9H10O5 |
 |
TopiraMate N-Methyl IMpurity |
97240-80-7 |
C13H23NO8S |
 |
セチリジンアミド |
83881-37-2 |
C21H26ClN3O2 |
 |
(S)-4-(((R)-1-carboxy-2-((3-hydroxypropyl)
thio)ethyl)amino)-3-methyl-4-oxobutanoic
acid |
|
|
 |
Lapatinib IMpurity 8 |
320337-48-2 |
C26H19ClFN3O3 |
 |
Isavuconazole Impurity |
21661-87-0 |
C9H5Br2NO |
 |
(2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane |
119302-24-8 |
C29H48N2O4 |
![1H-1,2,3-Triazole-4-methanol, 1-[(2,6-difluorophenyl)methyl]-](/CAS/20210305/GIF/1364193-40-7.gif) |
1H-1,2,3-Triazole-4-methanol, 1-[(2,6-difluorophenyl)methyl]- |
1364193-40-7 |
C10H9F2N3O |
 |
Brivaracetam Impurity B |
943986-67-2 |
C11H19NO3 |
 |
HERBA CIRSII JAPONICI |
|
|
 |
32-O-デメチルラパマイシン |
141392-23-6 |
C50H77NO13 |
 |
エナラプリルジケトピペラジン酸 |
115623-21-7 |
C18H22N2O4 |
![[18O3]-Chlorate](/) |
[18O3]-Chlorate |
|
|
 |
cefotaxiMe IMpurity D |
63527-53-7 |
C16H17N5O7S2 |
 |
Apixaban Impurity 24 |
1928718-22-2 |
C26H27N5O4 |
 |
Iohexol EP Impurity F |
1215856-35-1 |
C14H19I2N3O6 |
 |
Ribavirin IMp. A (EP) |
|
|
![5-[エチル(2-ヒドロキシエチル)アミノ]-2-ペンタノン](/CAS/GIF/74509-79-8.gif) |
5-[エチル(2-ヒドロキシエチル)アミノ]-2-ペンタノン |
74509-79-8 |
C9H19NO2 |
 |
L-Ampicillin |
19379-33-0 |
C16H19N3O4S |
 |
Rasagiline Dipropynyl HCl |
92850-02-7 |
C15H15N |
 |
Tadalafil EP IMpurity G |
|
|
![D-glycero-Heptaric acid, 2,4,6-trideoxy-2-[(1R)-1-hydroxyethyl]-6-imino-5-S-[2-[(iminomethyl)amino]ethyl]-5-thio-, 7,3-lactone, (3ξ,5ξ)-](/CAS/20211123/GIF/1193105-97-3.gif) |
D-glycero-Heptaric acid, 2,4,6-trideoxy-2-[(1R)-1-hydroxyethyl]-6-imino-5-S-[2-[(iminomethyl)amino]ethyl]-5-thio-, 7,3-lactone, (3ξ,5ξ)- |
1193105-97-3 |
C12H19N3O5S |
 |
クルクリゴシドB |
143601-09-6 |
C21H24O11 |
 |
Cilastatin Impurity A |
|
|
 |
7(4H)-Benzothiazolone, 2-amino-5,6-dihydro-6-(propylamino)-, (6S)- |
2204518-89-6 |
C10H15N3OS |
 |
Sildenafil EP IMpurity D |
1357931-55-5 |
C17H20N4O5S |